Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal salmeterol and fluticasone alone and in combination in allergic rhinitis
2005-005523-34Phase 4Terminated
- Sponsor
- University of Dundee
- Start
- Mar 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of salmeterol, fluticasone propionate and salmeterol + fluticasone in allergic rhinitis (AR) (4 arms), sponsored by University of Dundee. Primary endpoint: Percent maximum fall in Peak Nasal Inspiratory Flow after AMP challenge. Started Mar 2006; status: terminated.
02
Drugs
salmeterolfluticasone propionatesalmeterol + fluticasone
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on 2005-005523-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005523-34.